8-K: Wellgevity 360, Inc. and First Choice Healthcare Solutions Announce Business Combination
Business Combination Agreement
Wellgevity 360, Inc. (formerly Westin Acquisition Corp.) and First Choice Healthcare Solutions, Inc. have entered into a definitive agreement to combine, creating a publicly traded healthcare and wellness company.
Summary
- Wellgevity 360, Inc. (formerly Westin Acquisition Corp.) and First Choice Healthcare Solutions, Inc. have signed a definitive agreement for a business combination.
- The transaction aims to create a publicly traded healthcare and wellness company focused on longevity, preventative care, and personalized medicine.
- First Choice Healthcare Solutions will be valued at an equity value of up to approximately $650 million.
- The combined company will operate under the name Wellgevity 360, Inc. and is expected to trade on the Nasdaq.
- The transaction is anticipated to close in the fourth quarter of 2026, subject to regulatory and shareholder approvals.
- Concurrently with the business combination, First Choice Healthcare Solutions has agreed to acquire Pointe Med Entities.
- A PIPE investment of $12.5 million in preferred stock for $10 million is also part of the transaction.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a moderately positive development, as it signifies the completion of a SPAC's business combination target search and moves towards creating a public entity in a growing sector, though significant closing conditions and risks remain.
Positives
- The business combination is expected to accelerate First Choice Healthcare Solutions' rebrand to Wellgevity 360, a next-generation healthcare and wellness platform.
- The transaction values First Choice Healthcare at a pro forma enterprise value of approximately $650 million.
- The combined company is expected to trade on Nasdaq, providing enhanced public market access.
- The transaction is expected to close in Q4 2026, indicating a relatively defined timeline.
- The company is positioned to capitalize on the growing demand for primary care, wellness, and regenerative medicine services.
- The financial model for longevity medicine, with cash pay and membership programs, suggests a durable business.
Negatives
- The transaction is subject to numerous closing conditions, including regulatory approvals, shareholder approvals, and the effectiveness of a registration statement.
- There is a risk that the business combination may not be completed, leading to potential termination of the agreement.
- The combined company may face challenges in integrating operations and retaining key employees.
- The transaction involves significant legal and regulatory hurdles, including SEC filings and Nasdaq listing requirements.
Risks
- The occurrence of any event, change, or other circumstance that could give rise to the termination of the Business Combination Agreement.
- The outcome of any legal proceedings that may be instituted against Westin or the Company following the announcement.
- Inability to complete the Business Combination due to failure to obtain shareholder approvals or satisfy other closing conditions.
- Delays in obtaining or the inability to obtain necessary regulatory approvals.
- Inability to obtain or maintain the listing of PubCo Common Stock on Nasdaq following the Business Combination.
- The risk that the Business Combination disrupts current plans and operations.
- The ability to recognize the anticipated benefits of the Business Combination, affected by competition and the combined company's ability to grow and manage profitably.
- Changes in applicable Laws or regulations.
Future Outlook
The transaction is expected to close in the fourth quarter of 2026, subject to customary approvals and closing conditions. The combined company, Wellgevity 360, Inc., aims to scale its operations, invest in health technologies, and expand its services to a broader patient base.
Management Comments
- "The merger reflects our commitment to partnering with a company with an innovative healthcare platform, experienced management team and significant growth potential. We believe the Company is well positioned to capitalize on the growing demand for primary care, wellness and regenerative medicine services, and that this proposed transaction will provide the resources, public market access, and strategic flexibility needed to support its next phase of growth." Mr. Kok Peng Na, Chairman/CEO of Westin.
- "This business combination marks a transformative milestone for First Choice as we capitalize on the accelerating demand for longevity and functional medicine. By combining our clinical model with Westins public market access, we expect to be able to scale our operations rapidly, invest in cutting-edge health technologies, and expand our services to a broader patient base seeking to optimize their health span and lifespan." Mr. Lance Friedman, CEO of First Choice Healthcare Solutions, Inc.
Industry Context
StockSavvy.ai notes that the global wellness and longevity markets are experiencing significant expansion, driven by an aging demographic and a consumer shift towards proactive health and personalized medicine. The US wellness economy is valued at $2.1 trillion and growing, with per capita spending exceeding $6,000. This aligns with First Choice Healthcare Solutions' focus on functional health, longevity, and regenerative medicine.
Comparison to Industry Standards
- The US wellness economy is valued at $2.1 trillion, growing at an annual rate of 7.9% from 2019 to 2024.
- Wellness economy per capita spending in the US surpassed $6,000 in 2024.
- The wellness sector accounts for 7.33% of the US GDP.
- The global wellness economy reached $6.8 trillion and is forecast to expand at a 7.6% annual rate to approach $9.8 trillion by 2029.
- Millennials and Gen Z are driving a 'prejuvenation' trend, shifting med-spas and aesthetics clinics towards holistic longevity and screening centers.
- Genomics and nutraceuticals are significant revenue drivers in the longevity market.
- Emerging technologies like biomarkers and senolytics are seeing the fastest growth in precision medicine.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Initial Board of Directors | N/A | Five directors: one independent designated by Sponsor, three independent designated by Company (after consultation with Parent), and the Company's CEO. | Post-Closing | To establish the governance structure of the combined company. |
| Chairperson of the Board | N/A | Designated by the Company from among its designated directors and the Company's CEO. | Post-Closing | To establish the governance structure of the combined company. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Domestication | Westin Acquisition Corp. will de-register from the Cayman Islands and domesticate as a Nevada corporation, to be renamed Wellgevity 360, Inc. (PubCo). | Prior to Closing | Changes the legal domicile and corporate structure of the SPAC entity. |
| Merger | Merger Sub will merge with and into First Choice Healthcare Solutions, Inc., with First Choice surviving as a wholly owned subsidiary of PubCo. | Closing Date | Integrates the operating business under the SPAC's public shell. |
| Registration Rights Agreement | An Amended and Restated Registration Rights Agreement will be entered into, superseding the Prior Registration Rights Agreement, granting holders rights to register their securities. | Upon Closing | Establishes the framework for future public resales of securities by key holders. |
| Lock-Up Agreements | The Sponsor and certain Company officers, directors, and major stockholders will enter into lock-up agreements restricting the transfer of their PubCo Common Stock post-closing. | Upon Closing | Aims to stabilize the stock price post-combination by limiting immediate selling pressure from insiders. |
Legal Proceedings
- Potential legal proceedings may arise following the announcement of the Business Combination Agreement and Transactions.
Related Party Transactions
- The Sponsor and certain other Parent shareholders entered into a Parent Support Agreement, agreeing not to transfer or redeem their Parent Ordinary Shares and to vote in favor of the Business Combination.
- The Sponsor may have provided working capital loans to Parent, with associated Working Capital Loan Shares potentially becoming Registrable Securities.
Stakeholder Impact
- Shareholders of Westin Acquisition Corp. will become shareholders of the combined entity, Wellgevity 360, Inc., subject to dilution and the success of the business combination.
- Shareholders of First Choice Healthcare Solutions, Inc. will receive shares of PubCo Common Stock, effectively taking their company public.
- Employees of First Choice Healthcare Solutions, Inc. may experience changes in corporate structure and potential opportunities within a publicly traded company.
- The Sponsor (Westin Investment Co. Ltd.) will likely retain a significant stake and influence in the combined company.
Next Steps
- Prepare and file a registration statement on Form S-4 with the SEC.
- Obtain necessary regulatory approvals.
- Obtain approval from Westin and First Choice shareholders.
- Obtain approval for listing on Nasdaq.
- Consummate the Domestication and Merger.
- File an Amended and Restated Registration Rights Agreement.
- Enter into Lock-Up Agreements with specified holders.
Key Dates
| Date | Description |
|---|---|
| 2025-11-03 | Date of the Prior Registration Rights Agreement. |
| 2026-07-21 | Date of the press release announcing the definitive business combination agreement. |
| 2026-07-22 | Date of the Business Combination Agreement. |
| 2026-07-22 | Date of the Form 8-K filing reporting the Business Combination Agreement. |
| 2026-03-31 | Initial outside date for closing the Business Combination. |
| 2026-04-30 | Extended outside date for closing if Registration Statement not effective by February 28, 2027. |
| 2026-02-28 | Date by which Registration Statement must be declared effective for the initial outside date to be extended. |
| 2026-01-01 | Effective date of the Amended and Restated Registration Rights Agreement (assumed to be the Closing Date). |
Recommendation
holdThe announcement of a definitive business combination agreement is a significant step, but the transaction is still subject to numerous closing conditions, including regulatory and shareholder approvals. While the combination targets a growing market, the success of the combined entity will depend on execution and market conditions. A 'hold' recommendation reflects the uncertainty and the need for further developments, such as the effectiveness of the registration statement and shareholder votes, before a more definitive investment stance can be taken.
Keywords
Business Combination, Healthcare, Wellness, Longevity, Regenerative Medicine, SPAC, Registration Rights, Nasdaq Listing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.